Clinical trial NCT05770505: Use of E-health Based Exercise Intervention After COVID-19
Official title: Effect E-health Based Exercise Intervention After COVID-19
Study type: INTERVENTIONAL
Overall status: ACTIVE_NOT_RECRUITING
Phase: NA
Conditions: COVID-19
Lead sponsor: Norwegian University of Science and Technology
Sponsor class: OTHER
Collaborators: name: University of Oslo
First posted: 2023-03-15
Enrollment: 77
Sex: ALL
Minimum age (years): 18
Maximum age (years): 59
Standard ages: ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: PARALLEL
Primary purpose: TREATMENT

Brief summary: Reduced subjective and objective functional capacity performance are reported after COVID-19 in a large proportion of subjects. The aim of this study is to examine the feasibility and effect of using an e-health tool for guidance and tracking of exercise training in a general population of adults previously infected by COVID-19.

Detailed description: Both hospitalized and non-hospitalized persons who have undergone extensive multi-disciplinary rehabilitation programs report significantly improved physical function after rehabilitation. Exercise training may be the key intervention to improve fitness and subjective complaints such as fatigue, low physical fitness and dyspnea after COVID-19 infection. However, traditional group-based exercise training or self-training programs at fitness centers have been shut down during the pandemic, and home-based interventions are warranted. To overcome the limitations and costs of a fitness center/personal trainer-based intervention study, more knowledge on the effectiveness and efficacy of using an e-Health system to recruit, train and monitor participants after illness are needed.

Eligibility criteria: Inclusion Criteria:

* Persons who have undergone COVID-19 disease
* People who struggle to be physically active enough as a result of corona disease
* People who experience reduced physical fitness as a result of corona disease

Exclusion Criteria:

-- more than 100 PAI per week (calculated from self-reported activity level)

* uncontrolled hypertension (high blood pressure) (over 200/110).
* symptomatic valve failure, hypertrophic cardiomyopathy, unstable angina, pulmonary
* hypertension, heart failure and/or severe rhythm disturbances
* cancer that makes participation impossible or exercise contraindicated. Considered individually in consultation with the attending physician.
* chronic contagious infectious diseases.
* Participates in other studies that are not compatible with participation in this project
* Post-exertional symptom exacerbation (PESE)/post-exertional malaise (PEM)/post-exertional neuroimmune exhaustion (PENE).

Primary outcomes:
measure: Cardiorespiratory fitness
timeFrame: After 6 months intervention
measure: Feasibilty
timeFrame: After 6 months intervention
Secondary outcomes:
measure: Lung function
timeFrame: After 6 months intervention
measure: Quality of life
timeFrame: After 6 months intervention
Other outcomes:
Locations:
city: Trondheim
country: Norway
facility: Norwegian University of Science and Technology, Faculty of medicine, Department of circulation and medical imaging,
Study officials:
affiliation: Dorthe Stensvold, Professor, NTNU
name: Dorthe Stensvold Stensvold
role: PRINCIPAL_INVESTIGATOR
References: